Plasma p-tau217 successfully identified Alzheimer's pathology in several neurodegenerative syndromes. This included disorders not typically associated with Alzheimer's disease, like frontotemporal ...

Please provide your email address to receive an email when new articles are posted on . Cell transformation begins with slow degeneration and progresses rapidly. The data confirmed results from ...

A new study has found comprehensive evidence that "weight-loss" GLP-1 receptor agonists such as semaglutide are effective in ...

Can weight-loss drugs like semaglutide prevent Alzheimer's? New research reveals GLP-1 drugs reduce amyloid and tau proteins ...

ARUP Laboratories has introduced a blood test for phosphorylated tau 217 (pTau 217) to aid in diagnosing the pathology of Alzheimer's disease in individuals aged 60 years and above experiencing ...

Please provide your email address to receive an email when new articles are posted on . A clinical diagnostics company and biotech firm have announced a partnership to develop a blood-based tau ...

Alzheimer’s disease, the leading cause of dementia, is a multifactorial disorder involving amyloid beta (Aβ) and tau ...

Some brains resist Alzheimer's, even when the disease is already present. Researchers at the Netherlands Institute for ...

Harvard Medical School researchers studying mice and human tissues have found a link between lithium (Li) deficiency in the brain and the development of Alzheimer’s disease. Headed by Bruce Yankner, ...

Depressive symptoms were not consistently associated with Alzheimer's pathology in people without dementia. In people with normal cognition, amyloid and depressive symptoms were not linked. In people ...